Biogaran

Visit website

In January 2026, BC Partners acquired Biogaran, one of France’s largest generic drug companies

Biogaran, a leader in the generic market in France and an active contributor to cost savings in the French healthcare system, was founded over 25 years ago. Over the years, the company has established itself as a key player in the pharmaceutical industry. Today, Biogaran offers treatments across the full spectrum of therapeutic areas — from everyday conditions to the most serious diseases — and supplies a wide range of medicines, including antibiotics, antidiabetics, and anticancer drugs.

 

Sector
Healthcare
Strategy
Private Equity
Investment year
2021
Region
Europe
Investment status
Unrealised

Our partnerships

At BC, we provide our portfolio companies with the access and expertise to scale into leading global businesses. We are a partner for growth.

See full portfolio